Brief: Leap Therapeutics Announces Initiation Of New Dkn-01 Clinical Trials In Gastric Cancer, Colorectal Cancer And Endometrial Cancer
12/07/2022 12:21
July 12 (Reuters) - Beigene Ltd 6160.HK :
* LEAP THERAPEUTICS ANNOUNCES INITIATION OF NEW DKN-01
CLINICAL
TRIALS IN GASTRIC CANCER, COLORECTAL CANCER AND ENDOMETRIAL
CANCER
Source text for Eikon: ID:nPn1yvxvpa
Further company coverage: 6160.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cypherpunk Technologies
See all newsCypherpunk Technologies Inc reports results for the quarter ended June 30 - Earnings Summary
Cypherpunk Technologies swings to Q2 profit on Zcash gains
Cypherpunk Technologies Inc expected to post a loss of 3 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Chipotle Mexican Grill, J.B. Hunt, ABM Industries
U.S. STOCKS ON THE MOVE-G-III Apparel, Amneal Pharmaceuticals, BioCardia